General Information of Drug Inactive Ingredient (DIG) (ID: E00141)

DIG Name
Propyl 4-hydroxybenzoate
Synonyms
PROPYLPARABEN; Propyl 4-hydroxybenzoate; 94-13-3; Propyl paraben; 4-Hydroxybenzoic acid propyl ester; Propyl p-hydroxybenzoate; n-Propyl 4-hydroxybenzoate; Nipasol; Nipazol; Propyl parahydroxybenzoate; Propyl Butex; Betacide P; Propylparasept; Propagin; Chemacide pk; Chemocide pk; N-Propyl p-hydroxybenzoate; Propyl Parasept; Aseptoform P; p-Hydroxypropyl benzoate; Propyl Chemosept; Protaben P; Tegosept P; Propyl aseptoform; Nipagin P; Nipasol P; Solbrol P; Paseptol; 4-Hydroxybenzoic acid, propyl ester; Preserval P; Betacine P; Bonomold OP; Nipasol M; p-Hydroxybenzoic acid propyl ester; p-Hydroxybenzoic propyl ester; Propyl-4-hydroxybenzoate; Parasept; N-Propylparaben; Propyl chemsept; Propyl-paraben; Benzoic acid, 4-hydroxy-, propyl ester; n-propyl paraben; Benzoic acid, p-hydroxy-, propyl ester; UNII-Z8IX2SC1OH; Chemoside PK; Lexgard P; Pulvis conservans; p-Hydroxybenzoic acid, propyl ester; MFCD00002354; n-PROPYL-p-HYDROXYBENZOATE; propyl 4-oxidanylbenzoate; Z8IX2SC1OH; MLS002152934; CHEBI:32063; NSC23515; p-Hydroxybenzoic acid n-propyl ester; NCGC00090965-03; NCGC00090965-04; SMR000112070; DSSTox_CID_2527; WLN: QR DVO3; DSSTox_RID_76614; DSSTox_GSID_22527; Propyl parahydroxybenzoate;Propyl 4-hydroxybenzoate; Caswell No. 714; Propyl 4-hydroxybenzoate, 99+%; Propyl 4-hydroxybenzoate, >=99%; Bayer D 206; FEMA Number 2951; Pulvis conservans (VAN); CAS-94-13-3; FEMA No. 2951; HSDB 203; 1246820-92-7; p-Oxybenzoesaurepropylester [German]; EINECS 202-307-7; NSC 23515; p-Oxybenzoesaurepropylester; Propylparaben [USAN:NF]; EPA Pesticide Chemical Code 061203; BRN 1103245; AI3-01341; Propylester kyseliny p-hydroxybenzoove [Czech]; 4-Hydroxybenzoic acid propylester; 36M; Propylparaben (NF); Propylester kyseliny p-hydroxybenzoove; Propylparaben-[d7]; Propylparaben, USAN; ACMC-209rqc; 85403-59-4; Propylis parahydroxybenzoas; propyl para-hydroxybenzoate; SCHEMBL977; p-Oxybenzoesaeurepropylester; EC 202-307-7; cid_7175; n-propyl-p-hydroxy-benzoate; 4-10-00-00374 (Beilstein Handbook Reference); MLS002222346; MLS006011654; BIDD:ER0229; Propyl-4-Hydroxybenzoate,(S); CHEMBL194014; Propyl parahydroxybenzoate (TN); DTXSID4022527; BDBM70190; NSC8511; 4-Hydroxybenzoic acid-propyl ester; HMS2268K21; Propyl 4-hydroxybenzoate, BioXtra; Propyl parahydroxybenzoate (JP17); HY-N2026; NSC-8511; PROPYL PARA HYDROXY BENZOATE; ZINC1586788; Tox21_111048; Tox21_400012; 4-hydroxybenzoic acid n-propyl ester; ANW-40210; BBL023754; NSC-23515; s5405; SBB015060; STL294815; 4-Hydroxybenzoic acid, n-propyl ester; AKOS008948099; component of Heb-Cort MC (Salt/Mix); CCG-266432; DB14177; DS-3427; MCULE-6661199693; NCGC00090965-01; NCGC00090965-02; NCGC00090965-05; NCGC00090965-06; NCGC00090965-07; AK106260; E216; K713; ST075003; CS-0018518; FT-0618698; P1955; T8305; D01422; A844839; Propyl 4-hydroxybenzoate, p.a., 99.0-100.5%; Propyl Parahydroxybenzoate 0.01 mg/ml in Methanol; Propyl Parahydroxybenzoate 1.0 mg/ml in Methanol; Q511627; 4-Arm PEG-OMs, 95%, average M.W. 20,000; Q-201635; Propyl 4-hydroxybenzoate, SAJ first grade, >=98.0%; Propyl 4-hydroxybenzoate, tested according to Ph.Eur.; Propyl 4-hydroxybenzoate, Vetec(TM) reagent grade, 98%; Propylparaben, certified reference material, TraceCERT(R); UNII-AZF98361GV component QELSKZZBTMNZEB-UHFFFAOYSA-N; 4-Hydroxybenzoic acid-propyl ester 1000 microg/mL in Acetonitrile; Propylparaben, United States Pharmacopeia (USP) Reference Standard; Propyl parahydroxybenzoate, European Pharmacopoeia (EP) Reference Standard; Propylparaben, Pharmaceutical Secondary Standard; Certified Reference Material
DIG Function
Antimicrobial preservative
Formula
C10H12O3
Canonical SMILES
CCCOC(=O)C1=CC=C(C=C1)O
InChI
1S/C10H12O3/c1-2-7-13-10(12)8-3-5-9(11)6-4-8/h3-6,11H,2,7H2,1H3
InChIKey
QELSKZZBTMNZEB-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 180.2 Topological Polar Surface Area 46.5
XlogP 3 Complexity 160
Heavy Atom Count 13 Rotatable Bond Count 4
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3

Full List of Drug(s) Co-administrated with This DIG

36 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Acetaminophen DMUIE76 Allergic rhinitis [CA08.0] Acetaminophen 500 mg tablet F00390
Amantadine DMS3YE9 Influenza A virus infection [1E30] Amantadine 100 mg capsule F00918
Amoxicillin DMUYNEI Acute otitis media [AB00] Amoxicillin 250 mg capsule F01256
Aspirin DM672AH Acute coronary syndrome [BA41] Aspirin 325 mg tablet F01555
Benzonatate DM9U4FO Cough [MD12] Benzonatate 100 mg capsule F02350
Calcitriol DM8ZVJ7 Congenital alopecia [LC30] Calcitriol 0.0005 mg capsule F03163
Ceftibuten DMWV2AG Acute otitis media [AB00] Ceftibuten 400 mg capsule F03680
Chlordiazepoxide DMTN5XI Alcohol withdrawal [] Chlordiazepoxide 10 mg capsule F03980
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria [5C58.11] Chlorpromazine 100 mg tablet F04057
Clomipramine DMINRKW Depression [6A70-6A7Z] Clomipramine 25 mg capsule F04568
Cycloserine DMT1I52 Bacterial infection [1A00-1C4Z] Cycloserine 250 mg capsule F05160
Diphenhydramine DMKQTBA Hyperemesis gravidarum [] Diphenhydramine 25 mg capsule F06256
Dipyridamole DMXY30O Atrial fibrillation [BC81.3] Dipyridamole 25 mg tablet F06541
Disopyramide DM5SYZP Long QT syndrome [BC65.0] Disopyramide 100 mg capsule F06572
Ergocalciferol DMHO0AR Hypoparathyroidism [5A50] Ergocalciferol 50000 unt capsule F07340
Ethosuximide DMDZ9LT Epilepsy [8A60-8A68] Ethosuximide 250 mg capsule F07706
Flucytosine DM13VTW Cryptococcal meningitis [] Flucytosine 250 mg capsule F08398
Fluoxetine DM3PD2C Bipolar depression [] Fluoxetine 20 mg capsule F08473
Fluvastatin DM4MDJY Arteriosclerosis [BD40] Fluvastatin 20 mg capsule F08582
Gemfibrozil DMD8Q3J Hyperlipidaemia [5C80] Gemfibrozil 600 mg tablet F09081
Ibuprofen DM8VCBE Dysmenorrhea [GA34.3] Ibuprofen 200 mg tablet F10228
Imipramine DM2NUH3 Depression [6A70-6A7Z] Imipramine 100 mg capsule F10552
Isotretinoin DM4QTBN Acne vulgaris [ED80] Isotretinoin 10 mg capsule F10858
Loxapine DM8AI9U Bipolar disorder [6A60] Loxapine 10 mg capsule F12660
Methylergonovine DMBEX4O Spontaneous abortion [JA00.0] Methylergonovine 0.2 mg tablet F13519
Nifedipine DMSVOZT Angina pectoris [BA40] Nifedipine 20 mg capsule F15252
Nortriptyline DM4KDYJ Depression [6A70-6A7Z] Nortriptyline 10 mg capsule F15511
Oxazepam DMXNZM4 Alcohol withdrawal delirium [] Oxazepam 30 mg capsule F16101
Phenytoin DMNOKBV Epilepsy [8A60-8A68] Phenytoin 100 mg capsule F17220
Procarbazine DMIK367 Hodgkin lymphoma [2B30] Procarbazine 50 mg capsule F17912
Temazepam DM02A65 Insomnia [7A00-7A0Z] Temazepam 15 mg capsule F20761
Temozolomide DMKECZD Adenocarcinoma [2D40] Temozolomide 180 mg capsule F20846
Tetracycline DMZA017 Acne vulgaris [ED80] Tetracycline 250 mg capsule F21016
Trimipramine DM1SC8M Major depressive disorder [6A70.3] Trimipramine 50 mg capsule F21721
Valproate DMCFE9I Epilepsy [8A60-8A68] Valproic acid 250 mg capsule F22012
Verapamil DMA7PEW Angina pectoris [BA40] Verapamil 240 mg capsule F22403
------------------
⏷ Show the Full List of 36 Approved Drug(s)